摘要
Hepatocellular carcinoma(HCC) is the most common liver-derived malignancy with a high fatality rate. Risk factors for the development of HCC have been identified and are clearly described. However, due to the lack of tumor-specific symptoms, HCC are diagnosed at progressed tumor stages in most patients, and thus curative therapeutic options are limited. The focus of this review is on surgical therapeutic options which can be offered to patients with HCC with special regard to recent findings, not exclusively focused on surgical therapy, but also to other treatment modalities. Further, potential promising future perspectives for the treatment of HCC are discussed.
Hepatocellular carcinoma （HCC） is the most commonliver-derived malignancy with a high fatality rate. Riskfactors for the development of HCC have been identifiedand are clearly described. However, due to the lackof tumor-specific symptoms, HCC are diagnosed atprogressed tumor stages in most patients, and thuscurative therapeutic options are limited. The focus ofthis review is on surgical therapeutic options which canbe offered to patients with HCC with special regardto recent findings, not exclusively focused on surgicaltherapy, but also to other treatment modalities. Further,potential promising future perspectives for the treatmentof HCC are discussed.
基金
support by Oram D
